Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

ASSOCIATION FOR CLINICAL ONCOLOGY

Filed by ASSOCIATION FOR CLINICAL ONCOLOGY.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 17, 2025
Income
Not reported
Expenses
$250,000.00
Filing UUID
0a263869-de55-4926-b73b-a351db66c779
Termination date
Not reported

Expense method: B

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

S. 1261: CONNECT for Health Act- expands access to telehealth services under Medicare Medicare Physician Payment reforms: H. 879 - Medicare Patient Access and Practice Stabilization Act - Providing automatic inflationary updates to Medicare physician payments. Eliminate budget neutrality requirements. Meaningful changes to the Merit-Based Incentive Payment System (MIPS). Incentivizing the transition to value-based care including H.R. 786 - Preserving Patient Access to Accountable Care Act. Prior authorization reforms including H. 2433 - Reducing Medically Unnecessary Delays in Care Act and reintroduction of the Improving Seniors Timely Access to Care act. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. S. 705 - Innovation in Pediatric Drugs Act - to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations. Preserving the Medicaid Program for cancer patients.

Literal federal measure citations: S. 1261, H.R. 786, H.R. 1509, S. 752, S. 705

HCR · Health Issues

S. 864: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs S. 932: Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 1262: Give Kids a Chance Act - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Oncology Drug Shortages - Mitigate existing drug shortages and prevent future shortages of lifesaving and life-prolonging cancer drugs. HR 2484: Seniors' Access to Critical Medications Act - make permanent a waiver issued by the Centers for Medicare and Medicaid Services (CMS) that allowed for Medicare patients to receive critical medications by mail or allow for caregivers and family members to obtain medications for them. HR 2120/S 1031: ROCR Value Based Program Act - To amend title XVIII of the Social Security Act to create a Radiation Oncology Case Rate Value Based Payment Program exempt from budget neutrality adjustment requirements, and to amend section 1128A of title XI of the Social Security Act to create a new statutory exception for the provision of free or discounted transportation for radiation oncology patients to receive radiation therapy services. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes.

Literal federal measure citations: S. 864, S. 526, S. 932, HR 1262, HR 2484, HR 2120, S 1031, HR 929, S.266

TOB · Tobacco

Support banning the sale of menthol cigarettes and flavored cigars

BUD · Budget/Appropriations

FY 2025 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP) and palliative care research. FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP). House and Senate Budget Resolutions Indirect cost rate caps at the National Institutes of Health Proposed reorganizations and reductions in force at the Department of Health and Human Service

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.